A Comparison of the CNS Effects of Equivalent Doses of Escitalopram and Racemic Citalopram Using BOLD fMRI.

Trial Profile

A Comparison of the CNS Effects of Equivalent Doses of Escitalopram and Racemic Citalopram Using BOLD fMRI.

Completed
Phase of Trial: Phase IV

Latest Information Update: 31 Aug 2012

At a glance

  • Drugs Citalopram; Escitalopram
  • Indications Depression; Generalised anxiety disorder; Major depressive disorder; Obsessive-compulsive disorders; Panic disorder; Premenstrual dysphoric disorder; Social phobia
  • Focus Pharmacodynamics
  • Most Recent Events

    • 31 Aug 2012 Actual end date (1 Apr 2011) added as reported by ClinicalTrials.gov.
    • 11 Apr 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 01 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top